Melissa New, MD
Assistant Professor, Medicine-Pulmonary Sciences & Critical Care

Publications

• Ha DM, Nunnery MA, Klocko RP, Haverhals LM, Bekelman DB, New ML, Randhawa SK, Stevens-Lapsley JE, Studts JL, Prochazka AV, Keith RL. Lung cancer survivors' views on telerehabilitation following curative intent therapy: a formative qualitative study. BMJ Open. 2023 Jun 23;13(6):e073251. PubMed PMID: 37355268
• New ML, Amass T, Neumeier A, Huie TJ. Massive Hemoptysis Simulation Curriculum Improves Performance. Chest. 2023 Oct 16. [Epub ahead of print] PubMed PMID: 37852435
• New ML, Amass T, Neumeier A, Jacobson N, Huie TJ. Creation and Validation of a Massive Hemoptysis Simulator. Chest. 2023 Oct 16. [Epub ahead of print] PubMed PMID: 37852436
• Assante A, Lkhagvadorj K, Clambey ET, Danhorn T, Merrick DT, Keith RL, New ML, Degregori J, Miller YE, Ghosh M. Reduced Progenitor Function and Altered Immune Landscape Contribute to Field Cancerization of Lung Adenocarcinoma. Am J Respir Crit Care Med. 2023 Oct 15;208(8):903-905. PubMed PMID: 37639330
• New ML, Hirsch EA, Feser WJ, Malkoski SP, Garg K, Miller YE, Baron AE. Differences in VA and Non-VA Pulmonary Nodules: All Evaluations Are not Created Equal. Clin Lung Cancer. 2023 Jul;24(5):407-414. PubMed PMID: 37012147
• Hirsch EA, New ML, Brown SL, Malkoski SP. Results of a pilot risk-based lung cancer screening study: outcomes and comparisons to a Medicare eligible cohort. Discov Oncol. 2023 Aug 29;14(1):160. PubMed PMID: 37642787
• Hirsch EA, New ML, Brown SP, Barón AE, Malkoski SP. Patient Reminders and Longitudinal Adherence to Lung Cancer Screening in an Academic Setting. Ann Am Thorac Soc. 2019 Oct;16(10):1329-1332. PubMed PMID: 31339348